2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Stomach Neoplasms
135
Pancreatic Neoplasms
36
Esophageal Neoplasms
19
Biliary Tract Neoplasms
19
Colorectal Neoplasms
17
Esophageal Squamous Cell Carcinoma
12
Neoplasm Metastasis
10
Cholangiocarcinoma
8
Carcinoma, Non-Small-Cell Lung
7
Gastrointestinal Neoplasms
6
Nasopharyngeal Carcinoma
5
Colonic Neoplasms
5
Adenocarcinoma
5
Recurrence
4
Neoplasms
4
Head and Neck Neoplasms
4
Advanced Pancreatic Cancer
4
Advanced Gastric Cancer
4
Rectal Neoplasms
3
Gastric Adenocarcinoma
3
Gallbladder Neoplasms
3
Advanced Solid Tumors
3
Stage IV Gastric Cancer With Metastasis
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
NSCLC
2
Locally Advanced Pancreatic Cancer
2
Locally Advanced Gastric Cancer
2
Gastric Cancer Peritoneal Metastases
2
Carcinoma, Transitional Cell
2
Carcinoma, Hepatocellular
2
Interventions
Carboplatin
346
Cisplatin
240
Paclitaxel
208
Radiotherapy
207
Pemetrexed
190
Docetaxel
170
Gemcitabine
158
pembrolizumab
147
Erlotinib Hydrochloride
111
Magnetic Resonance Spectroscopy
102
Etoposide
99
Bevacizumab
96
Specimen Handling
84
Nivolumab
77
Radiosurgery
74
durvalumab
73
Blood Specimen Collection
65
Drug Therapy
61
osimertinib
56
Vinorelbine
54
Gefitinib
50
Surveys and Questionnaires
48
atezolizumab
45
Biopsy
43
Radiation
42
Irinotecan
42
Topotecan
39
Standard of Care
39
Cyclophosphamide
38
Surgical Procedures, Operative
35
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
S 1 (combination)
×
Clear all
NCT04274270
2020-03-19
SBRTLCES
Peking University Third Hospital
Phase NA
Unknown
60 enrolled